Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04384172 · ClinicalTrials.gov registry record · NA
Effect of Peripheral Neuromodulation on Vaginal Blood Flow
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT04384172: Completed NA study, sponsored by University of Michigan.
NCT04384172 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04384172, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The researchers want to see if nerve stimulation interventions cause a change in vaginal blood flow. This intervention was performed in women who have neurogenic (spinal cord injury) or non-neurogenic sexual dysfunction and healthy women.
Primary Outcome
VPA will be measured by a vaginal plethysmography transducer. A sensor placed in the vagina will measure changes in blood flow.
Interventions
- DEVICE Transcutaneous electrical nerve stimulation - Tibial Nerve
- DEVICE Transcutaneous electrical nerve stimulation - Genital Nerve
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2020-11-11 |
| Est. Completion | 2022-03-15 |
| Phase | NA |
What the finished NCT04384172 record still lists
NCT04384172 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Transcutaneous electrical nerve stimulation - Tibial Nerve is the first listed.
NCT04384172 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04384172 about?
NCT04384172 is a clinical study titled "Effect of Peripheral Neuromodulation on Vaginal Blood Flow". The researchers want to see if nerve stimulation interventions cause a change in vaginal blood flow. This intervention was performed in women who have neurogenic (spinal cord injury) or non-neurogenic sexual dysfunction and healthy women.
What is the current status of trial NCT04384172?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2020-11-11. Estimated completion is 2022-03-15.
What interventions are being tested in trial NCT04384172?
The interventions under investigation include: Transcutaneous electrical nerve stimulation - Tibial Nerve (DEVICE), Transcutaneous electrical nerve stimulation - Genital Nerve (DEVICE).
Who is sponsoring clinical trial NCT04384172?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04384172's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI